# Effectiveness of Statins on Lipid Goal Attainment and Lipid Parameters in PCI Patients

> **NCT02561845** · — · WITHDRAWN · sponsor: **AstraZeneca**

## Conditions studied

- PCI Patients

## Interventions

- **DRUG:** rosuvastatin

## Key facts

- **NCT ID:** NCT02561845
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-10
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2016-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02561845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02561845, "Effectiveness of Statins on Lipid Goal Attainment and Lipid Parameters in PCI Patients". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02561845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*